Clopidogrel (CED0001290)

Clopidogrel is an organic compound with the formula C16H16ClNO2S and an average molecular weight of 321.82 g/mol. Clopidogrel belongs to the amino acids, peptides, and analogues, a subclass of carboxylic acids and derivatives within the organic compounds. It acts as an antagonist of the P2Y purinoceptor 12 (P2RY12) protein target. The compound is utilized as an antithrombotic agent and is found in or released from ten recorded sources. These include healthcare, pharmaceuticals & veterinary products; drinking water & water supply (drinking water); food, food processing & cookware (preparation of wine or sparkling wine); household cleaning & consumer products (cigar cigarettes, non electric simulated smoking devices, and other smoking requisites); and electrical & electronic equipment (antennas, electrically stimulated smoking devices, magnets, and television systems). The recorded exposure route for clopidogrel is oral. In terms of health effects, clopidogrel is used as a treatment for acute myocardial infarction (PMC3291088), thrombosis (PMC9368651), stroke (PMC6044138, PMC9259378), and ischemic stroke (PMC3148418, PMC8084398, PMC9368651). Additionally, it has a therapeutic effect on thrombosis (PMC11124379) and stroke (PMC3148418).